**Exhibit      32.1**

**CERTIFICATION      OF **

**CHIEF      EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER **

**PURSUANT      TO 18 U.S.C. SECTION 1350**

| 1. | Such                Quarterly Report on Form 10-Q for the period ending March 31,                2008, fully complies with the requirements of section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The                information contained in such Quarterly Report on Form 10-Q for                the period ending March 31, 2008, fairly presents, in all                material respects, the financial condition and results of operations                of                Benda Pharmaceutical, Inc. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                May 20, 2008                                  |
|--------------------------------------------------------------------|
|                                                               |
| */s/                Yiqing Wan*                                    |  |
| Yiqing                WanPresident,                CEO andDirector |

----

**Exhibit      32.1**

**CERTIFICATION      OF **

**CHIEF      EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER **

**PURSUANT      TO 18 U.S.C. SECTION 1350**

| 1. | Such                Quarterly Report on Form 10-Q for the period ending March 31,                2008, fully complies with the requirements of section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The                information contained in such Quarterly Report on Form 10-Q for                the period ending March 31, 2008, fairly presents, in all                material respects, the financial condition and results of operations                of                Benda Pharmaceutical, Inc. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                May 20, 2008                                                                   |
|-----------------------------------------------------------------------------------------------------|
|                                                                                                |
| */s/                Eric Yu*                                                                        |  |
| Eric                YuCFO                and PrincipalAccounting                Officer andDirector |

----